Highlights and Quick Summary
- Non-operating Interest Expenses for the quarter ending March 31, 2022 was $213 Thousand (a -112.12% decrease compared to previous quarter)
- Year-over-year quarterly Non-operating Interest Expenses decreased by -47.54%
- Annual Non-operating Interest Expenses for 2021 was $1.29 Million (a 21.77% increase from previous year)
- Annual Non-operating Interest Expenses for 2020 was $1.06 Million (a 25.86% increase from previous year)
- Annual Non-operating Interest Expenses for 2019 was $843 Thousand (a -73.19% decrease from previous year)
- Twelve month Non-operating Interest Expenses ending March 31, 2022 was $1.27 Million (a -1.55% decrease compared to previous quarter)
- Twelve month trailing Non-operating Interest Expenses increased by 23.02% year-over-year
Trailing Non-operating Interest Expenses for the last four month:
31 Mar '22 | 31 Dec '21 | 30 Sep '21 | 30 Jun '21 |
---|---|---|---|
$1.27 Million | $1.29 Million | $3.21 Million | $1.03 Million |
Visit stockrow.com/ORGS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Interest Expenses of Orgenesis Inc.
Most recent Non-operating Interest Expensesof ORGS including historical data for past 10 years.Interactive Chart of Non-operating Interest Expenses of Orgenesis Inc.
Orgenesis Inc. Non-operating Interest Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $0.21 | – | – | – | – |
2021 | $-1.76 | $2.41 | $0.41 | $0.23 | $1.29 |
2020 | $0.16 | $0.24 | $0.34 | $0.33 | $1.06 |
2019 | $0.25 | $0.45 | $0.05 | $0.1 | $0.84 |
2018 | – | $-0.61 | $1.07 | $2.68 | $3.14 |
2017 | – | – | $-0.05 | $2.08 | $2.45 |
2016 | – | $2.08 | $0.0 | $0.0 | – |
2012 | – | – | – | – | $0.0 |
Business Profile of Orgenesis Inc.
Sector: Healthcare
Industry: Biotechnology